2010年广州市甲型H1N1流感病毒分离株NA基因变异分析

doi:10.3969/j.issn.1673-8640.2014.01.010

检验医学 ›› 2014, Vol. 29 ›› Issue (1): 42-48.DOI: 10.3969/j.issn.1673-8640.2014.01.010

2010年广州市甲型H1N1流感病毒分离株NA基因变异分析

许沙沙¹, 常彦敏², 徐霖³, 冯发深³, 何霞³, 王铸³, 张定梅³, 曹开源³

1.衡水市哈励逊国际和平医院检验科, 河北衡水 053000;
2.郑州大学附属肿瘤医院检验科, 河南郑州 450000;
3.中山大学临床检验标准化研究中心, 广东广州 510080

收稿日期:2013-02-27 出版日期:2014-01-20 发布日期:2014-01-20
通讯作者: 曹开源, 联系电话:020-87333339。
作者简介:许沙沙, 女, 1985年生, 硕士, 技师, 主要从事病毒免疫研究。
基金资助:
国家重大传染病防治科技重大专项(2009ZX10004-213);广东省重大传染病专项

Analysis on the NA gene variation of influenza A (H1N1) virus from Guangzhou in 2010

XU Shasha¹, CHANG Yanmin², XU Lin³, FENG Fashen³, HE Xia³, WANG Zhu³, ZHANG Dingmei³, CAO Kaiyuan³

1.Department of Clinical Laboratory, Harrison International Peace Hospital of Hengshui City, Hebei Hengshui 053000, China; 2.Department of Clinical Laboratory, Tumor Hospital, Zhengzhou University, Henan Zhengzhou 450000, China; 3.Research Center for Clinical Laboratory Standard, Sun Yat-Sen University, Guangdong Guangzhou 510080, China

Received:2013-02-27 Online:2014-01-20 Published:2014-01-20

摘要/Abstract

摘要： 目的比较2010年从广州市分离到的甲型H1N1流感病毒神经氨酸酶(NA)基因与2009年中国大陆甲型H1N1流感病毒NA基因的变异情况, 为甲型H1N1流感的监测和防控提供参考资料。方法收集2010年广州市有发热和呼吸道症状患者的咽拭子标本, 用甲型H1N1流感病毒特异性引物进行聚合酶链反应(PCR)检测, 扩增分离到的甲型H1N1流感病毒NA基因片段, 测序后与2009年的H1N1毒株进行比对和进化分析, 并用生物信息学方法对耐药位点和糖基化位点进行分析。结果共收集1 194份咽拭子标本, 检测到甲型流感病毒阳性327份, 其中H1N1流感病毒6株, 与2009年分离的甲型H1N1流感病毒相比, 有16个位点发生了有义突变, 3个位点和NA活性相关, 其中222位氨基酸的变异位于NA活性位点上。结果成功扩增了2010年广州市6株甲型H1N1流感病毒株NA基因并测序, 未发现H275Y耐药位点的变异。3毒株在NA活性位点222位、228位和425位等氨基酸位点处发生了变异, 需继续加强监测。

关键词: 甲型H1N1流感病毒, 神经氨酸酶, 耐药位点

Abstract: Objective To compare the variations of neuraminidase (NA) gene of influenza A (H1N1) virus from Guangzhou in 2010 and NA gene of influenza A(H1N1) virus from Chinese mainland in 2009, and to provide the reference for the surveillance and prevention of influenza A (H1N1) virus. Methods Specimens were collected from patients with febrile respiratory tract symptoms from Guangzhou in 2010. The specimens were determined with influenza A (H1N1) virus specificity primers by polymerase chain reaction (PCR). The fragment of NA gene was amplified. After sequencing, the Results were compared with influenza A (H1N1) virus in 2009.The drug resistance sites and glycosylation sites were analyzed by biometric software. Results A total of 1 194 specimens were collected, and 327 influenza A virus strains were detected, including 6 strains were identified with influenza A (H1N1) virus. Compared with influenza A (H1N1) virus in 2009, there were 16 amino acid sites with variation. There were 3 amino acid sites relating with NA activity. However, the amino acid site 222 located in the NA activity sites. Results NA gene of the 6 strains of influenza A (H1N1) virus are amplified and sequenced successfully, and H275Y drug resistant site is not found. The amino acid site 222, 228 and 425 locating in NA activity sites are found with mutations in 3 strains. Therefore, the monitoring should be strengthened.

Key words: Influenza A( H1N1) virus, Neuraminidase, Drug resistance site

中图分类号:

R373.1

许沙沙, 常彦敏, 徐霖, 冯发深, 何霞, 王铸, 张定梅, 曹开源. 2010年广州市甲型H1N1流感病毒分离株NA基因变异分析[J]. 检验医学, 2014, 29(1): 42-48.

XU Shasha, CHANG Yanmin, XU Lin, FENG Fashen, HE Xia, WANG Zhu, ZHANG Dingmei, CAO Kaiyuan. Analysis on the NA gene variation of influenza A (H1N1) virus from Guangzhou in 2010[J]. , 2014, 29(1): 42-48.

参考文献

[1] Fouchier RA, Munster V, Wallensten A et al. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls[J]. J Virol, 2005, 79(5): 2814-2822.
[2] Smith GJ, Vijaykrishna D, Bahl J, et al. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic[J]. Nature, 2009, 459(7250): 1122-1125.
[3] WHO. Pandemic (H1N1) 2009[EB/OL]. (2010-03-09)[2010-05-06]. http://www.who.int/csr/disease/swinflu/laboratory 19_03_2010/en/.
[4] Shortridge KF. Severe acute respiratory syndrome and influenza: virus incursions from southern China[J]. Am J Respir Crit Care Med, 2003, 168(12): 1416-1420.
[5] Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W:improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice[J]. Nucleic Acids Research, 1994, 22(22):4673-4680.
[6] Tamura K, Dudley J, Nei M, et al. MEGA4:mole-cular evolutionary genetics analysis (MEGA) software version 4.0[J]. Mol Biol Evol, 2007, 24(8):1596-1599.
[7] Bright RA, Shay DK, Shu B, et al. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States[J]. JAMA, 2006, 295(8): 891-894.
[8] 蓝雨, 李梓, 董丽波, 等. 中国H3N2亚型流感病毒烷胺类药物耐药性研究[J]. 中华实验和临床病毒学杂志, 2006, 20(2): 21-23.
[9] Centers for Disease Control and Prevention(CDC). Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009[J]. MMWR Morb Mortal Wkly Rep, 2009, 58(16): 433-435.
[10] Smith BJ, McKimm-Breshkin JL, McDonald M, et al. Structural studies of the resistance of influenza virus neuramindase to inhibitors[J]. J Med Chem, 2002, 45(11): 2207-2212.
[11] Monto AS, McKimm-Breschkin JL, Macken C, et al. Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use[J]. Antimicrob Agents Chemother, 2006, 50(7): 2395-2402.
[12] Colman PM, Hoyne PA, Lawrence MC. Sequence and structure alignment of paramyxovirus hemagglutinin-neuraminidase with influenza virus neuraminidase[J]. J Virol, 1993, 67(6): 2972-2980.
[13] Langedijk JP, Daus FJ, van Oirschot JT. Sequence and structure alignment of paramyxoviridae attachment proteins and discovery of enzymatic activity for a morbillivirus hemagglutinin[J]. J Virol, 1997, 71(8): 6155-6167.
[14] Hurt AC, Ernest J, Deng YM, et al.Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa[J]. Antiviral Res, 2009, 83(1): 90-93.
[15] Ferraris O, Lina B. Mutations of neuraminidase implicated in neuraminidase inhibitors resistance[J]. J Clin Virol, 2008, 41(1): 13-19.
[16] Deyde VM, Nguyen T, Bright RA, et al. Detection of molecular markers of antiviral resistance in in-fluenza A (H5N1) viruses using a pyrosequencing method[J]. Antimicrob Agents Chemother, 2009, 53(3): 1039-1047.
[17] Kiso M, Shinya K, Shimojima M, et al. Characterization of oseltamivir-resistant 2009 H1N1 pandemic influenza A viruses[J]. PLoS Pathog, 2010, 6(8):e1001079.
[18] Saxena SK, Mishra N, Saxena R, et al. Structural and antigenic variance between novel influenza A/H1N1/2009 and influenza A/H1N1/2008 viruses[J]. J Infect Dev Ctries, 2010, 4(1): 1-6.

2010年广州市甲型H1N1流感病毒分离株NA基因变异分析

Analysis on the NA gene variation of influenza A (H1N1) virus from Guangzhou in 2010

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 4

编辑推荐

Metrics

[1]	唐钧, 曹红梅. 甲型H1N1流感病毒RNA检测方法的建立及临床应用[J]. 检验医学, 2021, 36(7): 738-742.
[2]	田棣1，何静1，刘祎1，张万菊1，徐磊1，陈功祥2，周志统1，胡芸文1. 胶体金免疫层析试剂盒对甲型H1N1流感病毒（2009）抗原快速检测的敏感性分析[J]. 检验医学, 2013, 28(2): 154-158.
[3]	邹家凤;王晓燕;史小玲;杨向东;陈庄. 甲型H1N1流感病毒耐药性研究进展[J]. 检验医学, 2011, 26(08): 572-574.
[4]	石汉振;郑智明;黄宪章;方静. 免疫层析法用于甲型H1N1流感病毒抗原筛查的初步评价[J]. 检验医学, 2011, 26(06): 402-404.